Cambridge Investment Research Advisors, Inc. Opko Health, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$32.9 Billion
Q2 2025

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Opko Health, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 103,111 shares of OPK stock, worth $140,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,111

Previous 103,110 -0.0%

Holding current value

$140,230

Previous $171,000 20.47%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$1.24 - $1.66 $1 - $1	1 Added 0.0%	103,111 $136,000
Q4 2024 Feb 14, 2025	SELL	$1.4 - $1.64 $631 - $739	-451 Reduced 0.44%	103,110 $152,000
Q3 2024 Oct 28, 2024	SELL	$1.21 - $1.68 $1,257 - $1,745	-1,039 Reduced 0.99%	103,561 $154,000
Q2 2024 Jul 26, 2024	SELL	$1.21 - $1.42 $556 - $653	-460 Reduced 0.44%	104,600 $131,000
Q1 2024 Apr 24, 2024	SELL	$0.87 - $1.57 $9,725 - $17,551	-11,179 Reduced 9.62%	105,060 $126,000
Q4 2023 Feb 09, 2024	BUY	$1.23 - $1.63 $356 - $472	290 Added 0.25%	116,239 $176,000
Q3 2023 Oct 24, 2023	SELL	$1.5 - $2.17 $26,064 - $37,705	-17,376 Reduced 13.03%	115,949 $186,000
Q2 2023 Jul 13, 2023	BUY	$1.37 - $2.17 $1,850 - $2,931	1,351 Added 1.02%	133,325 $289,000
Q1 2023 May 11, 2023	SELL	$1.06 - $1.61 $3,248 - $4,934	-3,065 Reduced 2.27%	131,974 $193,000
Q4 2022 Feb 08, 2023	SELL	$1.05 - $2.01 $79,040 - $151,306	-75,277 Reduced 35.79%	135,039 $169,000
Q3 2022 Oct 17, 2022	SELL	$1.81 - $2.81 $92,536 - $143,661	-51,125 Reduced 19.56%	210,316 $397,000
Q2 2022 Jul 13, 2022	SELL	$2.33 - $3.61 $3,262 - $5,054	-1,400 Reduced 0.53%	261,441 $661,000
Q1 2022 May 12, 2022	SELL	$2.87 - $4.93 $14,774 - $25,379	-5,148 Reduced 1.92%	262,841 $904,000
Q4 2021 Feb 03, 2022	SELL	$3.52 - $5.15 $67,179 - $98,287	-19,085 Reduced 6.65%	267,989 $1.29 Million
Q3 2021 Nov 02, 2021	SELL	$3.44 - $4.24 $23,622 - $29,116	-6,867 Reduced 2.34%	287,074 $1.05 Million
Q2 2021 Aug 10, 2021	SELL	$3.33 - $4.55 $32,570 - $44,503	-9,781 Reduced 3.22%	293,941 $1.19 Million
Q1 2021 May 07, 2021	SELL	$4.19 - $5.99 $17,593 - $25,152	-4,199 Reduced 1.36%	303,722 $1.3 Million
Q4 2020 Feb 04, 2021	SELL	$3.27 - $4.87 $197,367 - $293,938	-60,357 Reduced 16.39%	307,921 $1.22 Million
Q3 2020 Oct 29, 2020	BUY	$2.99 - $5.96 $57,892 - $115,397	19,362 Added 5.55%	368,278 $1.36 Million
Q2 2020 Jul 27, 2020	SELL	$1.15 - $3.41 $31,854 - $94,457	-27,700 Reduced 7.35%	348,916 $1.19 Million
Q1 2020 May 08, 2020	SELL	$1.34 - $2.32 $11,357 - $19,664	-8,476 Reduced 2.2%	376,616 $504,000
Q4 2019 Feb 04, 2020	SELL	$1.42 - $2.17 $40,805 - $62,357	-28,736 Reduced 6.94%	385,092 $566,000
Q3 2019 Nov 06, 2019	SELL	$1.75 - $2.47 $9,999 - $14,113	-5,714 Reduced 1.36%	413,828 $864,000
Q2 2019 Aug 15, 2019	SELL	$1.79 - $2.61 $7,383 - $10,766	-4,125 Reduced 0.97%	419,542 $0
Q1 2019 May 08, 2019	BUY	$2.42 - $3.83 $197,007 - $311,792	81,408 Added 23.79%	423,667 $0
Q4 2018 Feb 05, 2019	SELL	$2.46 - $3.87 $109,083 - $171,607	-44,343 Reduced 11.47%	342,259 $1.03 Million
Q3 2018 Nov 02, 2018	SELL	$3.29 - $6.29 $106,734 - $204,060	-32,442 Reduced 7.74%	386,602 $0
Q2 2018 Aug 10, 2018	SELL	$2.99 - $4.99 $87,382 - $145,832	-29,225 Reduced 6.52%	419,044 $0
Q1 2018 May 09, 2018	SELL	$3.11 - $5.12 $127,382 - $209,710	-40,959 Reduced 8.37%	448,269 $0
Q4 2017 Feb 22, 2018	BUY	$4.61 - $7.04 $45,108 - $68,886	9,785 Added 2.04%	489,228 $0
Q3 2017 Nov 07, 2017	SELL	$5.88 - $7.11 $58,800 - $71,100	-10,000 Reduced 2.04%	479,443 $3.29 Million
Q2 2017 Aug 08, 2017	BUY	N/A	489,443	489,443 $3.22 Million

Others Institutions Holding OPK

# of Institutions

246

Shares Held

207M

Call Options Held

1.49M

Put Options Held

332K

View Full List

About OPKO HEALTH, INC.

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.05B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

More about OPK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Opko Health, Inc. Transaction History